Breast Cancer Rx and Heart Disease Risk
Researchers have known little about the use of aromatase inhibitors and heart disease risk in breast cancer survivors — until now.
Chemotherapy on the Brain
Despite past concerns, a new study found no link between a type of chemotherapy and cognitive decline in breast cancer survivors.
How Aspirin Might Affect Cancer Survival
Taking aspirin in low doses could help patients with cancer live longer, a new study found.
A New Job for Gilotrif
The US Food and Drug Administration has approved Gilotrif (afatinib) to treat squamous cell lung cancer.
Pembrolizumab Vs. Advanced Melanoma
Pembrolizumab may increase survival for patients with advanced melanoma, the deadliest form of skin cancer, according to a new study.
Fast Food May Mean More Phthalates
Fast food may expose diners to potentially harmful chemicals called phthalates, a new study found.
What's Behind the USPSTF's Aspirin Guidance
The US Preventive Services Task Force (USPSTF) just released new guidance on daily aspirin to prevent cardiovascular disease (CVD) and colorectal cancer. But what was behind that recommendation?
Is a Daily Aspirin Right for You?
The US Preventive Services Task Force (USPSTF) has issued a recommendation on taking aspirin for heart attack, stroke and colorectal cancer prevention for certain patients.
Another Reason to Avoid Processed Carbs
Sugar and other processed carbohydrates may be tied to a raised risk of cancer, a new study found.
FDA OKs First Rx for Rare Liver Condition
The US Food and Drug Administration (FDA) has approved Defitelio (defibrotide sodium) to treat adults and children with severe hepatic (liver) veno-occlusive disease (VOD).